HOWL

Insider Trades

Name	Value	Action	Price	Last Price
Evnin LukeDirector $12k29.7k shares SellJun 3, 2026 $0.42 $0.456
Evnin LukeDirector $13k29.6k shares SellJun 2, 2026 $0.45 $0.456
Evnin LukeDirector $38k80.5k shares SellJun 1, 2026 $0.47 $0.456
Evnin LukeDirector $15k32.6k shares SellMay 29, 2026 $0.45 $0.456
Evnin LukeDirector $13k27.7k shares SellMay 28, 2026 $0.46 $0.456
Evnin LukeDirector $39k80.9k shares SellMay 27, 2026 $0.48 $0.456

News

globenewswire.comWerewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updatesglobenewswire.comMay 7

globenewswire.comWerewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updatesglobenewswire.comMar 27

Trade HOWL

About Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory immune treatments. Key among its product pipeline are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule targeting advanced solid tumors, and WTX-330, an Interleukin-12 INDUKINE molecule also designed for conditional activation, intended for advanced or metastatic solid tumors or lymphomas that have relapsed or are refractory. Furthermore, Werewolf Therapeutics is progressing WTX-613, a conditionally activated interferon alpha INDUKINE molecule, for addressing solid tumors and hematologic malignancies. The company was founded in 2017 and operates from its headquarters in Cambridge, Massachusetts.

CEO: Daniel J. Hicklin
IPO Date: Apr 30, 2021

Market Data

Open: $0.454
High: $0.454
Low: $0.3869
Volume: 576.9K
52W High: $2.38
52W Low: $0.3869

Valuation

Market Cap: $19M
Enterprise Value: $10M

Financials

Free Cash Flow: $-60M
Revenue: $0
Net Income: $-61M
Cash: $58M
Debt: $9.4M

Events

EarningsAug 13

EPS est. -0.28